Thursday, October 9, 2025
HomePublic Health

Public Health

Public Health

Quarter of world may not get Covid vaccine until 2022: Study

Life Sciences Times - 0
Public Health

Poverty linked to higher risk of Covid-19 death: Study

Life Sciences Times - 0
Public Health

21% US adults not planning to get Covid vaccine: Survey

Life Sciences Times - 0
Public Health

San Francisco administers first Covid vax to health care workers

Life Sciences Times - 0
Pharma

Remdesivir may be highly effective against Covid: Study

Life Sciences Times - 0
Public Health

Senecio Robotics awarded US$12 Million from the European Commission to address mosquito borne diseases

Life Sciences Times - 0
Public Health

Communal Role of Cremation Specialists in Times of Pandemic

Life Sciences Times - 0
Public Health

FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine

Life Sciences Times - 0
Public Health

Tychan to Start COVID-19 Phase 3 Clinical Trial For Novel Monoclonal Antibody TY027

Life Sciences Times - 0
Public Health

LabCorp Receives FDA Authorization to Make At-Home COVID-19 Collection Kits Available Through Retail

Life Sciences Times - 0
Medtech

Faze Medicines Launches With $81 Million Series A Financing to Leverage New Biology of Biomolecular Condensates to Treat Disease

Life Sciences Times - 0
Public Health

Tremeau Pharmaceuticals Will Advance Non-Opioid Pain Program with Investment from Gurnet Point Capital

Life Sciences Times - 0
1...323334Page 33 of 34

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv